1-2 of 2
Helgi van de Velde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

Esperanza Martín-Sánchez, Laura Blanco, Peter S. Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesus F. San Miguel, Ana Alfonso, Juan Bergua, Rebeca Rodríguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Bruno Paiva, Aintzane Zabaleta
Journal: Blood Advances
Blood Adv (2024) 8 (15): 3875–3879.
https://doi.org/10.1182/bloodadvances.2024013212
Published: 2024
Includes: Supplemental data
Journal Articles

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma

Clinical Trials & Observations
Thomas Martin, Joseph Mikhael, Roman Hajek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatiana Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4506–4515.
https://doi.org/10.1182/bloodadvances.2021006713
Published: 2022